New Zealand drugs regulator approves use of MDMA to treat severe PTSD

New Zealand decision follows Australian approval in 2023 of psychedelics to treat PTSD and treatment-resistant depression Two psychiatrists in New Zealand won approval on Friday to prescribe pharmaceutical-grade MDMA to people with severe post-traumatic stress disorder (PTSD). The move by New Zealand’s pharmaceutical regulatory body Medsafe makes the country only the second worldwide to approve th